TY - JOUR
T1 - Global Registries and Surveys Programme–Heart Failure (GRASP-HF)
T2 - Rationale, study design and research implications
AU - GRASP-HF Study National Leaders and Investigators
AU - Chioncel, Ovidiu
AU - Savarese, Gianluigi
AU - Laroche, Cecile
AU - Amir, Offer
AU - Tokmakova, Mariya
AU - Cannata, Antonio
AU - Do Doan, Loi
AU - Kafafy, Tarek Abdelhameed Nagib Ahmed
AU - Krejci, Jan
AU - Moura, Brenda
AU - Lund, Lars
AU - Adamo, Marianna
AU - Guillouche, Wendy
AU - Volterani, Maurizio
AU - Iung, Bernard
AU - Metra, Marco
AU - Chioncel, O.
AU - Amir, O.
AU - Adamo, M.
AU - Cannata, A.
AU - Lund, L.
AU - Metra, M.
AU - Moura, B.
AU - Savarese, G.
AU - Tokmakova, M.
AU - Volterrani, M.
AU - Abir-Khalil, S.
AU - Abu-Hantash, H.
AU - Kafafy, T. Ahmed
AU - Alali, J.
AU - Antohi, E.
AU - Bekbossynova, M.
AU - Bosevski, M.
AU - Christodoulides, T.
AU - Dankova, M.
AU - Do Doan, L.
AU - Dupont, M.
AU - Elmet, M.
AU - Erglis, A.
AU - Gellen, B.
AU - Glavas, D.
AU - Grupper, A.
AU - Gurung, M.
AU - Ibrahimi, P.
AU - Krejci, J.
AU - Martins, E.
AU - Mirrakhimov, E.
AU - Pallangyo, P.
AU - Pawlak, A.
AU - Perrone-Filardi, P.
N1 - Publisher Copyright:
© 2025 European Society of Cardiology.
PY - 2025/11
Y1 - 2025/11
N2 - Heart failure (HF) is characterized by increasing prevalence, high morbidity and mortality, poor quality of life, and substantial healthcare costs. Despite advancements in pharmacologic and device-based therapies, translating evidence from randomized controlled trials into clinical practice remains suboptimal. The Global Registries and Surveys Programme–Heart Failure (GRASP-HF) is a pan-European, snapshot, observational study, aiming at assessing the real-world implementation of evidence-based HF management. GRASP-HF captures both acute and chronic HF presentations to assess the adherence to the 2021 and 2023 European Society of Cardiology (ESC) HF Guidelines. It also serves as a platform for the accreditation of HF centres for the Improving Care through Accreditation and Recognition in Heart Failure (ICARe-HF) programme. This manuscript outlines the rationale, methodology, and design of GRASP-HF. Unlike previous registries, GRASP-HF ensures that all patients are consecutively enrolled over a pre-defined 2-month period, minimizing selection bias. GRASP-HF offers a real-time perspective on diagnostic strategies, use of guideline-recommended medical therapy and implementation of quality-of-care indicators. In addition, GRASP-HF addresses less explored domains by other registries, such as frailty, rare aetiologies (e.g. amyloidosis, genetic cardiomyopathies, Takotsubo syndrome), as well as non-fatal events during hospitalization and follow-up. GRASP-HF is also designed to inform ESC educational strategies and to benchmark progresses in HF care across European and non-European centres. In conjunction with ICARe-HF, annual repetition of GRASP-HF aims to facilitate continuous feedback between evidence, practice, and quality improvement. GRASP-HF will assist National Cardiac Societies in shaping national and institutional policies and will contribute with data-driven insights to future guideline development.
AB - Heart failure (HF) is characterized by increasing prevalence, high morbidity and mortality, poor quality of life, and substantial healthcare costs. Despite advancements in pharmacologic and device-based therapies, translating evidence from randomized controlled trials into clinical practice remains suboptimal. The Global Registries and Surveys Programme–Heart Failure (GRASP-HF) is a pan-European, snapshot, observational study, aiming at assessing the real-world implementation of evidence-based HF management. GRASP-HF captures both acute and chronic HF presentations to assess the adherence to the 2021 and 2023 European Society of Cardiology (ESC) HF Guidelines. It also serves as a platform for the accreditation of HF centres for the Improving Care through Accreditation and Recognition in Heart Failure (ICARe-HF) programme. This manuscript outlines the rationale, methodology, and design of GRASP-HF. Unlike previous registries, GRASP-HF ensures that all patients are consecutively enrolled over a pre-defined 2-month period, minimizing selection bias. GRASP-HF offers a real-time perspective on diagnostic strategies, use of guideline-recommended medical therapy and implementation of quality-of-care indicators. In addition, GRASP-HF addresses less explored domains by other registries, such as frailty, rare aetiologies (e.g. amyloidosis, genetic cardiomyopathies, Takotsubo syndrome), as well as non-fatal events during hospitalization and follow-up. GRASP-HF is also designed to inform ESC educational strategies and to benchmark progresses in HF care across European and non-European centres. In conjunction with ICARe-HF, annual repetition of GRASP-HF aims to facilitate continuous feedback between evidence, practice, and quality improvement. GRASP-HF will assist National Cardiac Societies in shaping national and institutional policies and will contribute with data-driven insights to future guideline development.
KW - Guideline implementation
KW - Heart failure
KW - Registries
UR - https://www.scopus.com/pages/publications/105021343432
U2 - 10.1002/ejhf.70065
DO - 10.1002/ejhf.70065
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 41126578
AN - SCOPUS:105021343432
SN - 1388-9842
VL - 27
SP - 2061
EP - 2073
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
IS - 11
ER -